Opus Genetics IRD Accrued expenses and other liabilities
Accrued expenses and other liabilities at other companies
Other financials
Where this comes from
Reported directly by Opus Genetics in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities.
The official record: Opus Genetics’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Opus Genetics's accrued expenses and other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Opus Genetics's accrued expenses and other liabilities?
- Opus Genetics (IRD) reported accrued expenses and other liabilities of $432K in Q1 2026.
- How has Opus Genetics's accrued expenses and other liabilities changed year-over-year?
- Opus Genetics's accrued expenses and other liabilities increased by 58.8% year-over-year, from $272K to $432K.